99mTcPSMA‐radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE‐II trial

Objective To investigate whether combination treatment of prostate‐specific membrane antigen (PSMA)‐based radioguided surgery (RGS) with short‐term androgen deprivation therapy (ADT) improves oncological outcomes in men with oligorecurrent prostate cancer (PCa) as compared to treatment with short‐te...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2024-07, Vol.134 (1), p.81-88
Hauptverfasser:	Zuur, Lotte G., Barros, Hilda A., Oosterom, Matthias N., Berrens, Anne‐Claire, Donswijk, Maarten L., Hendrikx, Jeroen J.M.A., Bekers, Elise M., Vis, André N., Wit, Esther M., Leeuwen, Fijs B., Poel, Henk G., Leeuwen, Pim J.
Format:	Artikel
Sprache:	eng
Schlagworte:	99mTcPSMA androgen deprivation therapy Brachytherapy Computed tomography Lymph nodes Metastases oligorecurrent Patients Pelvis Positron emission tomography Prostate cancer prostate specific membrane antigen Prostatectomy Quality of life Radiation therapy radioguided surgery Surgery Survival Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!